168 related articles for article (PubMed ID: 20632063)
1. AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein: successful treatment by autologous stem cell transplantation.
Sakurai-Chin C; Ubara Y; Suwabe T; Hoshino J; Yonaha T; Hasegawa E; Sumida K; Hiramatsu R; Yamanouchi M; Hayami N; Yamauchi J; Tominaga N; Sawa N; Takemoto F; Masuoka K; Takaichi K; Oohashi K
Clin Exp Nephrol; 2010 Oct; 14(5):506-10. PubMed ID: 20632063
[TBL] [Abstract][Full Text] [Related]
2. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
Zeier M; Perz J; Linke RP; Donini U; Waldherr R; Andrassy K; Ho AD; Goldschmidt H
Nephrol Dial Transplant; 2003 Dec; 18(12):2644-7. PubMed ID: 14605290
[TBL] [Abstract][Full Text] [Related]
3. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
[TBL] [Abstract][Full Text] [Related]
4. The Long-term Outcomes after VAD plus SCT Therapy in a Patient with AL Amyloidosis and Severe Factor X Deficiency.
Iwadate D; Hasegawa E; Hoshino J; Hayami N; Sumida K; Yamanouchi M; Sekine A; Kawada M; Hiramatsu R; Suwabe T; Sawa N; Yuasa M; Wake A; Fujii T; Ohashi K; Takaichi K; Ubara Y
Intern Med; 2018 Mar; 57(5):701-706. PubMed ID: 29093408
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation.
Yamazaki O; Ubara Y; Suwabe T; Nakanishi S; Hoshino J; Sawa N; Hayami N; Yamanouchi M; Takemoto F; Kenmei T; Masuoka K; Oohashi K
Clin Exp Nephrol; 2009 Oct; 13(5):522-525. PubMed ID: 19499180
[TBL] [Abstract][Full Text] [Related]
6. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
7. Regression of renal amyloid deposits by VAD therapy plus autologous stem cell transplantation in a patient with primary AL amyloidosis.
Toriu N; Sawa N; Hiramatsu R; Mizuno H; Ikuma D; Sekine A; Hayami N; Sumida K; Yamanouchi M; Hasegawa E; Hoshino J; Takaichi K; Wake A; Ohashi K; Fujii T; Ubara Y
CEN Case Rep; 2020 Feb; 9(1):6-10. PubMed ID: 31522370
[TBL] [Abstract][Full Text] [Related]
8. Agammaglobulinemia, plasma cell dyscrasia, and amyloidosis in a 12-year-old child.
Pick AI; Versano I; Schreibman S; Ben-Bassat M; Shoenfeld Y
Am J Dis Child; 1977 Jun; 131(6):682-6. PubMed ID: 868821
[TBL] [Abstract][Full Text] [Related]
9. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis].
Kanoh T; Yago K; Okuma M
Rinsho Ketsueki; 1990 Oct; 31(10):1740-4. PubMed ID: 2255066
[TBL] [Abstract][Full Text] [Related]
10. IgD monoclonal gammopathy of undetermined significance.
Kinoshita T; Nagai H; Murate T; Saito H; Fukatsu T; Hotta T
Int J Hematol; 1997 Feb; 65(2):169-72. PubMed ID: 9071822
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
[TBL] [Abstract][Full Text] [Related]
12. Fibrillary glomerulonephritis associated with monoclonal gammopathy of undetermined significance showing lambda-type Bence Jones protein.
Nagao T; Okura T; Miyoshi K; Watanabe S; Manabe S; Kurata M; Irita J; Fukuoka T; Higaki J
Clin Exp Nephrol; 2005 Sep; 9(3):247-51. PubMed ID: 16189635
[TBL] [Abstract][Full Text] [Related]
13. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
[TBL] [Abstract][Full Text] [Related]
14. "Idiopathic Bence-Jones proteinuria": a new characterization of an old entity.
Mian M; Franz I; Wasle I; Herold M; Griesmacher A; Prokop W; Cortelazzo S; Gastl G; Willenbacher W; Gunsilius E; Fiegl M
Ann Hematol; 2013 Sep; 92(9):1263-70. PubMed ID: 23580149
[TBL] [Abstract][Full Text] [Related]
15. Renal AA amyloidosis in a patient with Bence Jones proteinuria and ankylosing spondylitis.
Quinton R; Siersema PD; Michiels JJ; ten Kate FJ
J Clin Pathol; 1992 Oct; 45(10):934-6. PubMed ID: 1430270
[TBL] [Abstract][Full Text] [Related]
16. A rare case of IgD gammopathy associated with free light-chain cryoglobulinemia and a gelling Bence Jones protein.
Myara I; Llirbat B; Rossert J; Cosson C; Tenenhaus P; Moatti N
Clin Chim Acta; 1993 Aug; 217(2):229-31. PubMed ID: 8261634
[No Abstract] [Full Text] [Related]
17. A patient with persistent renal AL amyloid deposition after clinical remission by HDM/SCT therapy.
Okuyama H; Yamaya H; Fukusima T; Yokoyama H
Clin Nephrol; 2013 Mar; 79(3):233-6. PubMed ID: 23439244
[TBL] [Abstract][Full Text] [Related]
18. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
[TBL] [Abstract][Full Text] [Related]
19. Prostatic cancer presenting monoclonal gammopathy: report of two cases.
Tsutsumi M; Hara T; Fukasawa R; Koiso K
Hinyokika Kiyo; 1993 Jun; 39(6):569-71. PubMed ID: 8337985
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
